TY  - JOUR 
AU  - M., Majem
AU  - O., Juan
AU  - A., Insa
AU  - N., Reguart
AU  - J.M., Trigo
AU  - E., Carcereny
AU  - García Campelo, María del Rosario
AU  - Y., Garcia
AU  - M., Guirado
AU  - M., Provencio
PY  - 2019
SN  - 1699-048X
UR  - http://hdl.handle.net/20.500.11940/16054
AB  - Non-small cell lung cancer (NSCLC) accounts for up to 85% of all lung cancers. The last few years have seen the development of a new staging system, diagnostic procedures such as liquid biopsy, treatments like immunotherapy, as well as deeper...
LA  - eng
KW  - Immunotherapy
KW  - Clinical Trials as Topic
KW  - Lung Neoplasms
KW  - Carcinoma
KW  - Radiotherapy
KW  - Humans
KW  - Combined Modality Therapy
KW  - Practice Guidelines as Topic
KW  - Prognosis
TI  - SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018)
DO  - 10.1007/s12094-018-1978-1
T2  - Clinical & Translational Oncology
M2  - Wed Mar 01 00:00:00 CET 2017
KW  - CHUAC
VL  - 21
ER  -